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Abstract
In Actinobacteria, protein O- mannosyl transferase (Pmt)- mediated protein O- glycosylation has an important role in cell enve-
lope physiology. In S. coelicolor, defective Pmt leads to increased susceptibility to cell wall- targeting antibiotics, including vanco-
mycin and β-lactams, and resistance to phage ϕC31. The aim of this study was to gain a deeper understanding of the structure 
and function of S. coelicolor Pmt. Sequence alignments and structural bioinformatics were used to identify target sites for an 
alanine- scanning mutagenesis study. Mutant alleles were introduced into pmt- deficient S. coelicolor strains using an integrative 
plasmid and scored for their ability to complement phage resistance and antibiotic hypersusceptibility phenotypes. Twenty- 
three highly conserved Pmt residues were each substituted for alanine. Six mutant alleles failed to complement the pmt▬ 
strains in either assay. Mapping the six corresponding residues onto a homology model of the three- dimensional structure of 
Pmt, indicated that five are positioned close to the predicted catalytic DE motif. Further mutagenesis to produce more conserva-
tive substitutions at these six residues produced Pmts that invariably failed to complement the DT1025 pmt▬ strain, indicating 
that strict residue conservation was necessary to preserve function. Cell fractionation and Western blotting of strains with the 
non- complementing pmt alleles revealed undetectable levels of the enzyme in either the membrane fractions or whole cell 
lysates. Meanwhile for all of the strains that complemented the antibiotic hypersusceptibility and phage resistance phenotypes, 
Pmt was readily detected in the membrane fraction. These data indicate a tight correlation between the activity of Pmt and its 
stability or ability to localize to the membrane.
INTRODUCTION
Protein glycosylation is a post- translational modification 
observed in all domains of life. The composition and structure 
of glycan moieties can vary greatly and their attachment to 
a target protein variously alters physicochemical proper-
ties, cellular localization, ligand binding, and stability [1]. 
Glycans are most commonly attached to serine/threonine 
(O- glycosylation) or asparagine (N- glycosylation) residues. 
Actinobacteria have a protein O- glycosylation system that 
resembles eukaryotic protein O- mannosylation. Two prin-
cipal enzymes in this pathway are polyprenol phosphate 
mannose synthase (Ppm1) and protein- O- mannosyl trans-
ferase (Pmt) [2]. Ppm1 initially synthesizes a sugar donor, 
polyprenol phosphate mannose (PPM), by catalysing the 
transfer of mannose from GDP- mannose to polyprenol 
phosphate on the cytoplasmic face of the plasma membrane 
(Fig. 1). The orientation of PPM is then thought to be flipped 
by an unknown mechanism so that the mannose residue is 
located on the periplasmic side of the cytoplasmic membrane. 
The protein- O- mannosyl transferase (Pmt) then transfers 
mannose from PPM to membrane and secreted proteins in the 
periplasm. This pathway is conserved across the eukaryotic 
kingdom where dolichol phosphate rather than polyprenol 
phosphate serves as the mannose carrier [1].
Recent studies of the actinobacteria, Mycobacterium tuber-
culosis and Corynebacterium glutamicum, have shown 
that strains deficient in Pmt activity have growth- retarded 
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coelicolor have greatly increased susceptibility to multiple cell 
wall targeting antibiotics including vancomycin, daptomycin 
and β-lactams [5, 6]. These strains are also resistant to infec-
tion by bacteriophage ϕC31, indicating that Pmt mediated 
mannosylation could be required for phage receptor forma-
tion [2]. S. coelicolor ppm1 mutants, and mutants in manB and 
manC (Fig. 1) that encode enzymes supplying GDP- mannose 
to Ppm1, all have similar phenotypes to pmt▬ strains but 
display more extreme antibiotic sensitivities [5]. PstS was the 
first, and for many years the only, known target of S. coeli-
color Pmt mediated mannosylation [7], however the recent 
characterisation of the S. coelicolor membrane glycoproteome 
led to the identification of thirty- seven novel glycoproteins, 
with diverse predicted roles including solute binding, poly-
saccharide hydrolysis, transport, and cell wall biosynthesis 
[8, 9]. Deletion of the genes encoding either of two of the 
cell wall active glycoproteins identified in that study, d- Ala- 
d- Ala carboxypeptidase and an l,d- transpeptidase resulted 
in strains that were hypersensitive to cell wall targeting 
antibiotics.
The role of glycoproteins in the maintenance of cell wall 
integrity is supported by studies in other mircoorganisms. In 
Candida albicans, knockout mutations in pmt affect growth, 
morphogenesis and antifungal resistance [9] while pmt 
knockouts are lethal in S. cerevisiae, S. pombe, Aspergillus 
fumigatus and Cryptococcus neoformans [10–13]. Meanwhile 
disruption of pmt homologues (POMT) in flies [14, 15], mice 
[16] and humans [17–20] is associated with a number of 
developmental disorders. Taken together, Pmt/POMT medi-
ated protein O- mannosylation is a fundamentally important 
protein modification in both prokaryotes and eukaryotes [1].
To gain a deeper understanding of Pmt from S. coelicolor, 
sequence alignments and structural bioinformatics were 
used to identify candidate residues for an alanine- scanning 
mutagenesis exploration of structure- activity relationships. In 
total, we constructed 23 distinct pmt mutant alleles and each 
was assessed for its capacity to complement phage sensitivity 
and antibiotic hyper- susceptibility phenotypes. Six mutant 
alleles failed to complement. Modelling suggested that the 
majority of the corresponding residues are positioned close 
to the active site and may therefore be involved in substrate 
binding and or catalysis. Further mutational analysis on each 
of the six residues showed that strict amino acid conservation 
is important to preserve function. Purification of membrane 
fractions and their analysis by Western blotting showed 
that non- complementing Pmt proteins routinely failed to 
localize to the membrane. These data show a tight correlation 
between the activity of Pmt and its stability and/or ability to 
be correctly localized in the membrane and are suggestive of 
the existence of a quality control mechanism.
METHODS
Bacterial strains
The genotypes of bacterial strains used in this work are 
listed in Table S1 (available in the online version of this 
article). Streptomyces coelicolor strains with mutations in pmt 
(DT1025; frameshift from codon Ala121, and DT2008; muta-
tion uncharacterised) are derived from the ϕC31 sensitive, 
parent strain J1929 (pglY▬) [21, 22]. Streptomyces strains were 
routinely maintained on mannitol soya (MS) agar at 30 °C and 
spore stocks were stored in 20 % glycerol at −38 °C. The dam▬, 
Fig. 1. Model for protein O- mannosylation in S. coelicolor. GDP- mannose is synthesised from mannose in consecutive reactions catalysed 
by ManA, ManB and ManC before transfer of the sugar onto polyprenol phosphate by polyprenol phosphate mannose synthetase (Ppm1). 
The polyprenol phosphate mannose is flipped to the periplasmic face of the membrane where it is a substrate for Pmt catalysed 
mannosylation of secreted protein substrates.
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dcm▬ methylation deficient E. coli strain ET12567 (pUZ8002) 
was used as a donor for plasmid conjugation with Strepto-
myces acceptor strains. E. coli DH5α was used for genetic 
manipulation and propagation of plasmids. E. coli strains 
were routinely grown in LB or on LB containing 0.4 % agar.
DNA manipulations
Plasmid DNA was introduced into chemically competent 
E. coli cells by transformation as described previously. 
Plasmids were purified from E. coli using a Spin Miniprep 
kit (QIAGEN), in accordance with the manufacturer’s 
instructions. Introduction of plasmids into S. coelicolor was 
performed by conjugation [23, 24]. After mixing donor E. coli 
ET12567 (pUZ8002) containing the plasmid to be transferred 
and recipient S. coelicolor spores and plating on mannitol soya 
flour agar (MSA) +10 mM MgCl
2
, conjugation plates were 
incubated at 30 °C for 18 h. Selection for ex- conjugants was 
performed by overlaying the plates with 1 ml sterile MilliQ 
H
2
O containing 0.5 mg nalidixic acid and 0.5 mg hygromycin. 
For each conjugation reaction, four ex- conjugant colonies 
(each representing a biological replicate) were picked after 
a 7 day incubation, resuspended in water and streaked onto 
MS agar containing hygromycin (50 μg ml−1). Single colonies 
from these plates were picked after 7 days at 30 °C, and ampli-
fied to generate spore stocks that could be stored at −38 °C in 
20 % glycerol. pmt alleles transferred to S. coelicolor by conju-
gation and integration were validated by PCR and sequencing 
(Table S2 and GATC Services, Eurofins). Genomic DNA from 
Streptomyces strains was prepared using the CTAB method as 
described [25].
Plasmid constructions
The plasmids used in this work are all derivatives of the expression 
vector pIJ10257 [26] in which the wild- type or mutant pmt gene is 
inserted into the NdeI site downstream of the constitutive ermEp* 
promoter (Table S3). Plasmids were constructed as follows: DNA 
fragments were amplified by PCR using primer pairs listed in 
Table S2 from a J1929 genomic DNA template. To amplify pmt 
and simultaneously introduce a site- directed mutation, two 
separate PCR reactions were carried out using S. coelicolor J1929 
genomic DNA as the template. The first reaction contained primer 
IpmtF and a reverse mutagenic primer (such as R82AR) to amplify 
a fragment comprising the 5′ end of the gene. In the second reac-
tion, the reverse primer IpmtR and a forward mutagenic primer 
(such as R82AF) were used to amplify a fragment comprising the 
3′ end of the gene. Phusion Hi- Fidelity Polymerase and a Biometra 
TProfessional Basic Thermocycler (Thistle Scientific) were used 
according to the manufacturer’s instructions with the following 
reaction conditions: an initial incubation at 98 °C for 1 min, 30 
cycles of 98 °C/10 s, 60 °C/30 s, 72 °C/2 min and finally an incuba-
tion at 72 °C for 10 min. The PCR products were digested with 
DpnI (NEB) to remove template DNA and purified using QIA 
Quick PCR Purification Kit (QIAGEN). The pairs of amplified 
products corresponding to each mutant were joined together and 
cloned into NdeI (NEB) digested pIJ10257 using the In- Fusion 
HD Cloning Kit (Clontech). Then 5 µl of each reaction product 
was introduced into chemically competent DH5α E. coli by 
transformation. The restriction endonuclease NdeI and Phusion 
High- Fidelity DNA Polymerase were obtained from New England 
Biolabs (NEB).
Conjugation from E. coli
The method of intergeneric conjugation was followed as 
previously described [24].
Antibiotic disc diffusion assay
Approximately 1×107 Streptomyces spores were evenly spread 
on a Difco nutrient (DN) agar plate. Sterile filter discs (5 mm 
width) were prepared from grade 17 chromatography paper 
(GE Healthcare Whatman) and placed on the plate surface. 
Then 10 µl of antibiotic stock solution was pipetted on to the 
disc. Plates were incubated at 30 °C for 36 h and the diameter 
of the zone of no growth around the disc measured in order 
to quantify antibiotic susceptibility. Four biological replicates 
were tested for each strain.
Phage plaque assay
ϕC31cΔ25 is a clear plaque derivative of the temperate phage, 
ϕC31 [27]. The phage plaque assay was carried out in accord-
ance with the protocols described [25].
Preparation of S. coelicolor membrane fractions
S. coelicolor membrane fractions were isolated as previously 
described [7, 8, 25]. Briefly, mycelium from Streptomyces 
liquid cultures were grown at 30 °C in Difco nutrient broth 
(DNB) for 48 h, centrifuged (2 min, 3500 g), washed (20 mM 
Tris- HCl pH 8, 4 °C) and stored at −80 °C. Mycelial pellets 
were resuspended in two volumes of lysis buffer (20 mM Tris-
 HCl pH 8, 4 mM MgCl
2
, 4 mM DTT containing a protease 
inhibitor tablet (Roche)). Mycelium was lysed by sonication 
using a Sonicator 3000 (Misonix) (10 cycles of 30 s pulse and 
60 s cooling). Debris was removed by centrifugation (30 min, 
5525 g followed by 30 min at 13 500 g, 4 °C). Membranes were 
finally pelleted by ultracentrifugation (1 h at 100 000 g, 4 °C) 
The membrane pellet was resuspended in 20 mM Tris- HCl 
pH 8 to yield the membrane fraction while the supernatant 
constituted the soluble fraction.
SDS-PAGE and Western blotting
Protein concentrations were determined using a Nanodrop 
2000 instrument (Thermo Scientific). Membrane and 
soluble fractions were diluted to ~3 mg ml−1 in 1 × RunBlue 
LDS sample buffer (Expedeon) with β-mercaptoethanol 
(5 % vol/vol), and then incubated at 37 °C for 1 h prior to 
separation in RunBlue 4–12 % gradient SDS protein gels 
(Expedeon). For protein staining, gels were soaked in 
InstantBlue protein stain (Expedeon). Proteins were then 
transferred to 0.45 µm Amersham Hybond PVDF Blotting 
Membrane (GE healthcare) using the XCell II Blot Module 
(Invitrogen). Transfer was carried out at 30 V for 1 h. The 
preparation of the membrane for Western blotting (washing 
steps and antibody addition) was carried out according 
to the manufacturer’s instructions for the StrepII tag 
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antibody- HRP conjugate (Novagen). Chemiluminescent 
substrate for the Western blot was prepared by adding 5 ml 
of 100 mM Tris- HCl, pH 8.5, buffer with 0.2 mM p- coumaric 
acid (Sigma) and 1.25 mM luminol to 15 µl of 3 % (vol/vol) 
hydrogen peroxide solution. Under dark room conditions, 
membranes were incubated with chemiluminescent solu-
tion for 1 min. After exposure to the blot, the X- ray film 
(GE healthcare) was incubated for 1–3 min in developer 
solution (Kodak) and 30 s in fixer solution (Kodak). The 
film was rinsed in water and allowed to dry.
Pmt bioinformatics
Pairwise and multiple protein sequence alignments were 
produced using EMBOSS Needle and Clustal Omega 
[28, 29]. S. coelicolor Pmt homology models were produced 
using Phyre2 [30], which utilised Cupriavidus metallidurans 
ArnT [31] and S. cerevisiae Pmt1- Pmt2 [32] as templates. 
Protein structures were visualised using CCP4mg [33]. 
Construct design and sequence trace analysis was carried 
out using SnapGene (GSL Biotech).
RESULTS AND DISCUSSION
Identification of targets for site-directed 
mutagenesis
In order to probe structure- function relationships in 
protein mannosyl transferase from S. coelicolor, its sequence 
was aligned with those of homologues in prokaryotes (S. 
griseus, M. smegmatis and M. tuberculosis) and eukaryotes 
(S. cerevisiae and H. sapiens). The catalytic GT- 2 domain is 
broadly conserved across the prokaryotic and eukaryotic 
kingdoms (Fig. S1). Twenty- three conserved residues were 
identified as targets for alanine- scanning mutagenesis: R82, 
D113, E114, V158, H159, P161, K164, R182, R201, R228, 
L231, L232, D233, K302, R338, P393, W400, H410, S421, 
W426, P503, R510, F564. The majority of these residues 
were targeted on the basis of sequence conservation alone. 
Some residues, however, are implicated in having a func-
tional role from previous work. These include D113 and 
E114 which constitute the conserved DE motif, a hallmark 
of GT- C fold glycosyl transferases [34]. In S. cerevisiae 
Pmt1P, mutation of both homologous residues (Pmt1PD77, 
Pmt1PE78) led to notable reductions in in vivo glyco-
sylation and complete elimination of in vitro mannosyl 
transferase activity [35]. Elsewhere, mutations in the DE 
motif of M. tuberculosis Pmt (Mtb PmtD55, Mtb PmtE56) 
revealed that the in vitro mannosyl transferase activity was 
reduced, but not completely eliminated [36]. In an earlier 
study, R138 in S. cerevisiae Pmt1P (R182 in S. coelicolor) 
was shown to have an essential role in in vitro transferase 
activity [37]. Finally, in Cupriavidus metallidurans ArnT, 
a lipid A glycosyl transferase, the mutation of D55, K85 
and K203 (D113, H159 K302 in S. coelicolor respectively) 
eliminated in vivo function [31].
Predicted membrane topology of S. coelicolor Pmt
According to TMHMM (Transmembrane Helices; Hidden 
Markov Model), S. coelicolor Pmt is predicted to have 11 
transmembrane helices (Figs 2 and S2) ranging in length from 
17 to 22 residues. The majority of the 23 residues substituted 
in this study are predicted to be located in extracellular loop 
regions. Seven residues (D113, E114, V158, H159, P161, K164 
and R182) are predicted to occupy loop 1 and five residues 
(P393, W400, H410, S421 and W426) are predicted to reside 
in loop 7. Another four residues (R228, L231, L232 and D233) 
are on the shorter loop 3 and the beginning of TM4, while 
residues K302 and R510 occupy loops 5 and 9 respectively 
(Fig. 2). The hallmark DE motif is located within loop 1, as is 
universally observed in Pmt homologues across the prokary-
otic and eukaryotic kingdoms [34].
Fig. 2. Protein mannosyl transferase topology model. Predicted membrane topology model for Pmt. The limits of the 11 membrane 
spanning segments as predicted in TMHMM are specified along with the locations of the residues (red) mutated to alanine in this study. 
Italics denote mutated residues predicted to be within the transmembrane regions.
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Three of the substituted residues are predicted to be located 
on the cytoplasmic side of Pmt, with R82 in the N- terminal 
region and residues R201 and R338 located in loops 2 and 6 
respectively. Finally, two of the mutated residues are predicted 
to occupy the transmembrane spanning portion of Pmt, 
with residues P503 and F564 located on helices 9 and 11 
respectively.
The 82 N- terminal residues preceding the first predicted 
transmembrane helix of S. coelicolor Pmt encompass roughly 
55 amino acids that are predicted to be intrinsically disor-
dered according to IUPred2A (≥0.5) (Fig. S2c). Moderate 
peaks in disorder tendency (<0.5) are seen in shorter regions 
elsewhere.
Identification of conserved residues essential for 
Pmt function
The twenty- three conserved residues identified above 
were changed to alanine by site- directed mutagenesis. The 
activity of Pmts expressed from the twenty- three mutant 
alleles was then assayed using in vivo complementation. 
Using the integrative vector pIJ10257, S. coelicolor wild- 
type and mutant pmt alleles were introduced into the chro-
mosomes of the pmt deficient strain DT1025, and the parent 
strain J1929. DT1025 has a frameshift mutation in pmt and 
is hyper- susceptible to a number of antibiotics compared 
to its parent, J1929 (Fig.  3, [6]). The antibiotic hyper- 
susceptibility phenotype of DT1025 is complemented by the 
introduction of a wild- type copy of the pmt gene such that 
the sensitivities to the antibiotics, ampicillin, carbenicillin, 
vancomycin, imipenem, meropenem, rifampicin and nitro-
furantoin are restored to the levels seen in J1929 (Fig. 3) 
[5]. Six of the twenty- three pmt mutant alleles tested failed 
to complement the antibiotic susceptibility phenotype 
conferred by the pmt- mutation in DT1025 (Fig. 3). These 
non- complementing alleles encoded PmtR82A, PmtD113A, 
PmtH159A, PmtD233A, PmtK302A and PmtR510A. The 
wild- type (WT) and the seventeen remaining mutant alleles 
were able to complement DT1025, alleviating the antibiotic 
susceptibility phenotype (Fig. 3).
As described previously, DT1025 is most susceptible to 
membrane and cell wall biosynthesis targeting antibiotics, 
although this strain is also more sensitive to rifampicin, 
which targets RNA polymerase [6]. As an aside, a greater 
variety of antibiotics was tested for changes in antibiotic 
susceptibility. DT1025 was found to have increased suscep-
tibility to nitrofurantoin, an antibiotic that inhibits multiple 
enzymes that participate in bacterial carbohydrate metabo-
lism, in addition to interfering with cell wall synthesis [38]. 
DT1025 transformed with the empty plasmid control, and 
all of the non- complementing mutant strains exhibited very 
similar levels of susceptibility to antibiotics inhibiting DNA 
replication (ciprofloxacin, sparfloxacin and mitomycin C) 
and translation (doxycycline, minocycline, lincomycin, 
spectinomycin, thiostrepton) as the J1929 parent strain 
(P<0.05) (Fig. S3), further supporting the envelope- 
defective nature of the pmt- phenotype.
The complementing and non- complementing DT1025 
strains were also tested for other phenotypes of the pmt▬ 
mutants, described previously these being resistance to 
phage ϕC31 (Fig. 4, Table 1) and a small colony phenotype 
when grown on Difco Nutrient agar (Fig. S3). DT1025 
strains containing the mutant alleles that failed to rescue 
the DT1025 antibiotic susceptibility phenotype (encoding 
Pmt with R82A, D113, H159A, D233A, K302A and R510A 
substitutions) or the empty vector (negative control) 
showed no evidence of infection by ϕC31cΔ25 within the 
phage dilution range tested (Fig. 4). The positive control 
harbouring wild- type pmt and the seventeen complemented 
DT1025 strains from the antibiotic susceptibility assay were 
vulnerable to phage infection (Fig. 4) and yielded large, clear 
plaques phenotypically similar to those formed on the J1929 
parent strain (not shown). DT1025 strains harbouring pmt 
alleles associated with phage ϕC31 resistance exhibited slow 
growth and gave rise to small colonies on DN agar plates 
(Fig. S4). Thus, all of the strains found to be hypersensitive 
to antibiotics were also resistant to bacteriophage ϕC31 
infection and exhibited growth defects, while the strains 
that were complemented for antibiotic hypersusceptibility, 
without exception, were sensitive to phage ϕC31 infection 
and exhibited normal growth rates.
Since DT1025 encodes a frameshift mutation at the codon 
encoding A121, it is plausible that some of the mutant alleles 
encode proteins that could interact with this truncated 
Pmt to yield a functional enzyme. The dominance/reces-
sive nature of the mutations was therefore tested following 
introduction of the twenty- three mutant pmt alleles into the 
J1929 parent strain. No significant changes in susceptibility 
of J1929 to any of the antibiotics tested were observed nor 
was there any change in phage sensitivity/plaque forma-
tion (data not shown). These observations indicate that 
the wt pmt allele is dominant and that none of the non- 
complementing alleles has a dominant negative effect (Table 
S4).
The ability of the mutant pmt alleles to complement a 
different pmt▬ mutant strain, DT2008 was also studied [6]. 
Although the lesion in DT2008 pmt remains unknown, 
DT2008 is fully complemented by addition of a wt pmt. If 
the complementation profiles in DT1025 had been affected 
by the expression of the truncated endogenous Pmt, the 
same effect was deemed unlikely to occur in a different 
genetic background. In addition, our observation that 
alleles encoding PmtE114A and R182A successfully comple-
mented the pmt▬ mutation in DT1025 was surprising as 
homologous residues in S. cerevisiae and M. tuberculosis 
Pmts are known to be important for activity [35–37]. We 
therefore confirmed the consistency of complementation by 
PmtE114A and PmtR182A and the other alanine variants in 
the different genetic background of DT2008. The antibiotic 
susceptibility (Figs S5 and S6) and phage infection (Fig. S7, 
Table S5) data were fully consistent with those obtained in 
the DT1025 strains.
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Pmt mutations affect protein abundance and 
localization
We sought next to establish whether the inability of non- 
complementing Pmt variants was due to changes in enzyme 
stability or abundance. To assess the expression levels of the 
various pmt alleles and to determine the protein localiza-
tion, we used PCR methods to attach a sequence encoding 
a StrepII tag (WSHPQFEK) upstream or downstream of the 
coding sequence of the wt pmt allele and the six pmt mutant 
alleles that failed to complement the pmt▬ phenotypes. 
Fig. 3. Antibiotic sensitivity assays for DT1025 transformants. DT1025 strains harbouring genes encoding Pmt variants were assayed 
for their sensitivity to cell wall/membrane targeting antibiotics, nitrofurantoin and rifampicin. Antibiotic sensitivity was quantified by 
measuring the zone of inhibition in disc diffusion assays. Shown are the averages of four biological replicates with SEM. The antibiotic 
paper discs have a diameter of 5 mm, which is shown as the dotted line threshold. The amount of antibiotic used in μg is shown in 
brackets. The asterisks indicate a P<0.05 that the observed differences occurred by chance.
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The sequences encoding the N- and C- terminally tagged 
enzymes were introduced into pIJ10257 and then into the 
pmt deficient strains DT1025 and DT2008. DT1025 and 
DT2008 containing the wt pmt derivatives remained suscep-
tible to ϕC31cΔ25 infection. As expected, upon exposure 
to ϕC31cΔ25, no plaques were seen for either DT1025 
(Table 2) or DT2008 (Table S6) strains encoding the N- and 
C- terminally tagged Pmt variants (PmtR82A, PmtD113A, 
PmtH159A, PmtD233A, PmtK302A and PmtR510A) that 
led to loss of complementation. We conclude that the pres-
ence and position of the StrepII tag does not interfere with 
Pmt function in vivo.
An anti- StrepII tag antibody was used to probe for the pres-
ence of Pmt by Western blotting of cell fractions that had 
been resolved by SDS polyacrylamide gel electrophoresis. 
DT1025 expressing the WT C- terminally StrepII- tagged 
Pmt yielded a signal for a protein in the membrane fraction 
with a mobility between those of the 50 and 70 kDa marker 
proteins (Fig. 5a). As the calculated molecular weight (MW) 
of StrepII- tagged Pmt is 66 kDa, and because the empty 
vector control fractions yielded no signal, we conclude this 
band is Pmt. Surprisingly, none of the six non- functional 
tagged Pmt variants were detected in either the soluble or 
membrane fractions of the DT1025 strains (Fig. 5a) or the 
DT2008 strains (Fig. S8a).
Attempts were made to locate the tagged non- functional 
Pmt variants in the fractions that had been discarded during 
cell fractionation. Fractions were taken at intermediate 
Fig. 4. ϕC31cΔ25 Phage infection assays. DT1025 strains harbouring genes encoding Pmt variants were assayed for their sensitivity to 
ϕC31cΔ25 phage infection. Phage were plated out on the right side of DN agar plates and spores were subsequently streaked from left 
to right (from the regions lacking phage to those containing phage). Plates were incubated at 30 °C for 48 h. Images are representative 
of four biological replicates.
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steps in the differential centrifugation protocol (i. sonica-
tion, ii. 5000 g spin and iii. 15 000 g spin) but no detectable 
signal for the StrepII tag was obtained by Western blotting 
(data not shown) implying that the Pmt variant proteins 
were not present. Genomic DNA from the DT1025 strains 
was purified and sequences spanning the pmt genes at the 
integration site and at the native locus (including 100 base 
pairs upstream and downstream) were amplified by PCR. 
Sequencing of the PCR products in all cases confirmed the 
presence of the expected pmt alleles, the integrity of the 
integration site, and the absence of any unexpected changes 
to the DNA sequences (data not shown).
The failure to detect the StrepII- tagged Pmt proteins 
expressed from the six non- complementing pmt alleles 
was surprising given that alanine substitutions normally 
preserve native protein structure - by simply truncating 
the residue side- chain they represent a minor perturbation 
[39]. To test for a potential activity - localisation relation-
ship, Strep II tags were added to a subset of variant Pmts 
that had complemented the pmt▬ phenotypes in DT1025 
and DT2008. Six alleles were chosen encoding PmtP160A, 
PmtK164A, PmtR228A, PmtL231A, PmtR335A and 
PmtS421A. StrepII tags were attached to the periplasm 
facing C- termini using PCR and Infusion cloning, and the 
recombinant plasmids were introduced into DT1025 and 
DT2008 via pIJ10257. Phage susceptibility testing showed 
that all of the resulting strains were vulnerable to phage 
infection as expected (Tables 2 and S6). Membrane fractions 
from these strains were purified as described above. Signal 
corresponding to all of the active Pmt variants was present 
in the membrane fractions and absent from the soluble 
fractions from DT1025 (Fig. 5b) and DT2008 strains (Fig. 
S8b). Moreover, the intensity of the signals obtained and 
the mobility of the associated proteins was similar to that 
observed for the wild- type StrepII- tagged Pmt.
Table 1. Complemented DT1025 strains are vulnerable to ΦC31 cΔ25 
Phage infection. Phage were plated out on DN agar and then SN agar 
containing spores was added to the top with the plates incubated at 
30 °C for 18 h. The average titre is shown  ±SEM from four biological 
replicates. We used 0.1 ml of a 10−6 phage stock dilution to obtain 
countable plaques for phage sensitive strains. Strains that showed no 
plaques at the lowest phage stock dilution tested (10−1) are represented 
as having a PFU ml−1 <1×102


























Table 2. The presence of the Strep II Tag does not affect the ability of 
pmt alleles to complement DT1025. ΦC31 cΔ25 phage were plated out 
on DN agar and SN agar containing spores was overlaid and the plates 
were incubated at 30 °C for 18 h. The average titre is shown ±SEM from 
four biological replicates. We used 0.1 ml of a 10−6 phage stock dilution 
to obtain countable plaques for phage sensitive strains. Strains that 
showed no plaques at the lowest phage stock dilution tested (10−1) are 
represented as having a PFU ml−1 <1×102
C- terminal Strep II Tag N- terminal Strep II Tag
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Conservative substitutions can abolish Pmt activity
The mutations hitherto described caused substitutions to 
alanine. Alanine substitution usually preserves protein folding 
and stability while removing functional groups on side chains 
[39]. The phenotypes of the strains obtained in the present 
study were binary with respect to antibiotic and phage suscep-
tibility, resembling either J1929, suggesting the Pmt mutant 
is fully active or DT1025 (or DT2008) suggesting the Pmt 
mutant is inactive. We therefore sought to identify partially 
active Pmts, which would be evidenced by strains with inter-
mediate phenotypes and in which the variant Pmts localise 
to the cell membrane. We made a set of more conservative 
mutations at the positions where alanine substitution led to 
loss of activity. These substitutions were selected variously to 
preserve charge, polarity and/or size. Thus, R82 was mutated 
to lysine and histidine; H159 to lysine and asparagine; D233 
to glutamate and asparagine; K332 to histidine and arginine; 
R510 to histidine and lysine; and finally D113 was mutated to 
glutamate and asparagine. As before, the mutant alleles were 
cloned into pIJ10257, and subsequently introduced into the 
pmt deficient strain DT1025 by conjugation.
Antibiotic susceptibility tests were carried out to see if an 
intermediate phenotype had been obtained (Fig. S9). A 
limited selection of antibiotics was tested: ampicillin, vanco-
mycin, imipenem and meropenem. DT1025 expressing the 
pmt mutants encoding PmtR82K, PmtD113N, PmtD233E 
complemented the pmt▬ mutation and had similar antibiotic 
susceptibilities as J1929. The remaining nine strains exhibited 
antibiotic susceptibilities at levels comparable to the empty 
plasmid negative control indicating that these pmt alleles 
failed to complement. In phage infectivity assays, a similar 
profile was observed; three of the 12 strains, those with 
alleles expressing PmtR82K, PmtD113N and PmtD233E were 
susceptible to infection by ϕC31 (Table 3) while the remaining 
nine alleles failed to complement DT1025 and remained 
resistant. Finally, expression and localisation experiments 
with Strep- II tagged derivatives and Western blotting revealed 
(i) signals corresponding to the expected molecular weight in 
membrane fractions from strains complemented with alleles 
encoding PmtR82K, PmtD113N and PmtD233E (Fig. S10) 
and (ii) the absence of any such signals for the remaining nine 
alleles/strains. Expansion of the mutant library to include 
Fig. 5. Expression assays. C- terminal StrepII- tagged Pmt is absent (a) and present (b) in the membrane fractions of DT1025 strains 
harbouring non- complementing (alanine substitutions at positions 83, 113, 159, 233, 302 and 510) and complementing (alanine 
substitutions at positions 160, 164, 228, 231, 335 and 421) mutations respectively. Membrane and soluble fractions were loaded onto 
a 12 % SDS- PAGE gel, which was run and stained with Coomassie blue (upper images) to ensure that the protein concentrations in the 
samples were comparable. After transfer of proteins from an SDS- PAGE gel to a PVDF membrane and washing, the membrane was 
incubated with a StrepII- Tag Antibody HRP Conjugate, substrate was added and chemoluminescence was detected on an X- ray film 
(lower image). pIJ: pIJ10257 control, WT: Pmt WT complemented strain control.
Table 3. The majority of conservative substitutions yielded pmt alleles 
that could not complement DT1025. ΦC31 cΔ25 phage were plated on 
DN agar, then SN agar containing spores was added to the top and the 
plates incubated at 30 °C for 18 h. The average titre is shown  ±SEM 
from four biological replicates. We used 0.1 ml of a 10−6 phage stock 
dilution to obtain countable plaques for phage sensitive strains. Strains 
that showed no plaques at the lowest phage stock dilution tested (10−1) 
are represented as having a PFU ml−1 <1×102
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conservative and semi- conservative substitutions therefore 
failed to break the strict activity- expression/localisation 
relationship, strengthening the hypothesis that Pmt activity 
is required for membrane localisation.
A model of S. coelicolor Pmt structure based on 
homology
The Phyre2 Web Portal [30] was used to generate a homology 
model of S. coelicolor Pmt (UNIPROT Q9RKD3). This 
returned a model containing 445 residues representing 75 % of 
the sequence with 100 % confidence using as the top template 
Chain B (Pmt2) of the protein O- mannosyltransferase Pmt1-
 Pmt2 complex from S. cerevisiae (PDB ID: 6P2R) [32]. The 
structure of this complex, determined by cryo- EM, reveals 
structurally similar subunits that form a heterodimer with 
pseudo two- fold symmetry [32]. The Pmt1 and Pmt2 subu-
nits have 24 and 29% amino acid sequence identity with S. 
coelicolor Pmt. The homology model, shown in Fig. 6 encom-
passes residues 80–129, 155–257, 280–442 and 457–590. It 
is in good agreement with the topological predictions made 
by TMHMM and comprises 11 transmembrane helices, 
connected by generally shorter segments on the cytoplasmic 
side and longer segments on the periplasmic face. The missing 
segments from the model belong to the cytoplasmic domain 
(residues 1–79) at the N- terminus, the periplasmic segments 
connecting transmembrane helices TM1/TM2 (residues 
130–154) and TM7/TM8 (residues 443–456), and the cyto-
plasmic segment connecting TM4/TM5 (residues 258–279). 
Among the residues mutated in this study, Arg82, Arg201 
and Arg338 are predicted to be cytoplasm facing with the 
remaining residues located on periplasmic segments of the 
polypeptide (Fig. 6a).
Prediction of Pmt enzyme mechanism
In the structure of the yeast Pmt1- Pmt2 complex, a tetrapep-
tide, Pro- Tyr- Thr- Val, is bound in the acceptor site of Pmt2 
while the donor site of Pmt1 is occupied by a molecule of 
dolichol- phosphate, the reaction product [32]. These ligands 
are displayed in the context of the S. coelicolor model in Fig. 6(a) 
as part of a superposition that effectively defines the active 
site. In the course of the Pmt reaction, the hydroxyl group on 
a serine/threonine side chain of the protein substrate (analo-
gous to Thr3 in Fig. 6b) is activated for nucleophilic attack on 
the anomeric carbon of the mannose component of PPM. The 
mannose moiety is not present in the Pmt1- Pmt2 structure 
but its anomeric carbon (C
1
) would be covalently attached to 
the phosphate of PPM. Analogy with other Pmts implies the 
reaction proceeds with inversion of stereochemistry at the 
anomeric carbon so that the covalent linkage to this carbon 
from the acceptor protein is on the opposite side of the sugar 
ring to that made to the donor polyprenol- phosphate. As 
illustrated in Fig. 6(b), five of the six residues whose mutation 
Fig. 6. Phyre2 homology model of S. coelicolor Pmt. (a) Worms/tubes rendering of the overall structural model in the programme 
CCP4mg [33]. The chain is colour ramped from the amino terminus (magenta) to the carboxyl terminus (red). The peptide (Pro- Tyr- Thr) 
and polyprenol phosphate ligands derived from the S. cerevisiae Pmt1- Pmt2 coordinate set (6p25) are displayed in the context of the 
model following the overlay of protein chains using the ‘Superpose models’ routine in CCP4mg. Transmembrane helices are numbered 
1 to 11 and horizontal helices on the periplasmic face of the membrane are numbered HH1 to HH5. The Cα atoms of residues mutated 
in this study are displayed as spheres - white for mutations that were associated with complementation of pmt deficiency in the in vivo 
assays and black for those that were not. A selection of these residues is labelled. (b) Close- up view of the active site region of the model. 
The peptide and polyprenol phosphate are displayed in cylinder format with the Cα and side chains of five of the six residues whose 
mutation to alanine led to loss of complementation of pmt deficiency in the in vivo assays. Atoms are coloured as follows: nitrogens, blue; 
oxygens, red; phosphorus, magenta; carbons light green for ligands and grey for protein.
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to alanine leads to a defective in vivo phenotype, are in close 
proximity to the putative reaction centre. Asp113 is well 
placed to act as a base in activating the Ser/Thr hydroxyl of 
the protein substrate. Even though the mannose component 
is not present in the modelled complex, it is apparent that 
the side chains of His159, Lys302 and Arg510 are well- placed 
to orient the phosphate group of the mannosyl- phosphate 
moiety and facilitate charge transfer onto the phosphate. The 
remaining 15 periplasm- facing residues, whose mutation to 
alanine does not lead to a Pmt- defective phenotype in our 
assays, are further removed or oriented away from the active 
centre in the modelled structure. Meanwhile Arg82 whose 
mutation to alanine does cause a defective Pmt phenotype is 
located at the beginning of TM1 on the cytoplasmic face of 
the enzyme where it is unlikely to affect catalysis but could 
conceivably affect stability.
In contrast to alanine, substitutions of PmtD113, PmtD233 
and PmtR510 with asparagine, glutamate and lysine respec-
tively yielded active enzymes. The activity of the D113N 
mutant argues against a role for D113 as a catalytic base since 
asparagine is not readily ionisable. The loss of activity in the 
D113E mutant implies precise positioning of the polar side 
chain may be more important that its charge. Substitutions of 
the corresponding aspartate residue to glutamate or aspara-
gine in the aminoarabinose transferase, ArnT, from C. metal-
lidurans led to loss of function [31]. In the ArnT reaction, the 
sugar is transferred from a lipid donor to a lipid acceptor in 
a reaction that leads to cationic antimicrobial peptide resist-
ance. The aspartate of the DE motif aspartate in ArnT acts 
as a base to activate a nucleophilic phosphate on the lipid A 
acceptor substrate, rather than activating a serine or threonine 
hydroxyl as is the case for S. coelicolor Pmt.
Only active Pmts appear to be stably expressed and 
localized
The results of the mutagenesis analysis are readily reconciled 
with the homology model of S. coelicolor Pmt insofar as resi-
dues closest to the seat to the transferase reaction exhibited the 
strongest effects on phenotype in our in vivo assays following 
their substitution by alanine. Curiously, however, we did not 
observe ‘activity- deficient’ proteins in Western blots of S. 
coelicolor extracts from strains harbouring the StrepII- tagged 
Pmt variants, suggesting either that their coding sequences 
are not being expressed or that the encoded proteins are being 
produced but then rapidly degraded. It is conceivable that 
the six point mutants that failed to complement the pmt▬ 
strains, encode proteins which are prone to misfolding and 
or aggregation. In E. coli, misfolded membrane proteins are 
degraded by the ATP- dependent zinc metalloprotease FtsH 
which itself is membrane localized [40]. A homologue of FtsH 
(Uniprot Q9×814) exists in S. coelicolor which may perform 
a similar function. It is not obvious however, why alanine 
substitutions of residues R82, D113, H159, D233, K302 or 
R510 would have such drastic effects on stability. Alanine 
is considered to be a conservative substitution in structural 
terms [39] and each of these ionisable residues is expected to 
be located on the enzyme surface, an expectation consistent 
with the homology model.
It has been suggested that yeast protein O- mannosyltransferase 
activity is metal dependent [32] although no active site 
metal was observed in the Pmt1- Pmt2 crystal structure. This 
suggestion is based on its structural similarity to the oligo-
saccharyltransferase, PglB from Campylobacter lari [41], in 
which four side chain carboxylates coordinate an active site 
Mn2+. Two of these carboxylates participate in the activation 
of the amide nitrogen of the acceptor asparagine by a twisted 
amide mechanism. It is conceivable that Pmt from S. coeli-
color also requires a divalent metal ion for activity. If so, loss 
of metal coordination induced by mutations such as those 
introduced here would be a possible explanation for a drastic 
loss of stability.
CONCLUSION
Across our panel of substitution mutants, complementation 
of pmt deficiency was associated with detectable levels of Pmt 
protein on Western blots while failure to complement was 
always associated with the absence of detectable protein. Given 
the conservative character of the substitutions introduced, we 
conclude that activity and protein stability/localisation are 
tightly linked. The molecular basis of this activity- stability 
relationship remains unknown although one possibility is that 
mannosylation of one or more Pmt substrates is essential for 
Pmt stability.
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